These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38666616)

  • 41. Liquid-liquid phase separation in Alzheimer's disease.
    Fu Q; Zhang B; Chen X; Chu L
    J Mol Med (Berl); 2024 Feb; 102(2):167-181. PubMed ID: 38167731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intermediate Antiparallel β Structure in Amyloid β Plaques Revealed by Infrared Spectroscopic Imaging.
    Holcombe B; Foes A; Banerjee S; Yeh K; Wang SJ; Bhargava R; Ghosh A
    ACS Chem Neurosci; 2023 Oct; 14(20):3794-3803. PubMed ID: 37800883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A brief overview of amyloids and Alzheimer's disease.
    Ow SY; Dunstan DE
    Protein Sci; 2014 Oct; 23(10):1315-31. PubMed ID: 25042050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging Methods for Structural Analysis of Protein Aggregation.
    Khan E; Mishra SK; Kumar A
    Protein Pept Lett; 2017; 24(4):331-339. PubMed ID: 28176657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent structural and computational insights into conformational diseases.
    Fernàndez-Busquets X; de Groot NS; Fernandez D; Ventura S
    Curr Med Chem; 2008; 15(13):1336-49. PubMed ID: 18537613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.
    Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS
    Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
    Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
    Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer's Disease.
    Huang CC; Isidoro C
    J Alzheimers Dis; 2017; 57(4):1145-1156. PubMed ID: 28304304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tip-enhanced Raman spectroscopy reveals the structural rearrangements of tau protein aggregates at the growth phase.
    Sofińska K; Seweryn S; Skirlińska-Nosek K; Barbasz J; Lipiec E
    Nanoscale; 2024 Mar; 16(10):5294-5301. PubMed ID: 38372161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Raman Spectroscopy: An Emerging Tool in Neurodegenerative Disease Research and Diagnosis.
    Devitt G; Howard K; Mudher A; Mahajan S
    ACS Chem Neurosci; 2018 Mar; 9(3):404-420. PubMed ID: 29308873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimodal Spectroscopic Study of Amyloid Fibril Polymorphism.
    VandenAkker CC; Schleeger M; Bruinen AL; Deckert-Gaudig T; Velikov KP; Heeren RM; Deckert V; Bonn M; Koenderink GH
    J Phys Chem B; 2016 Sep; 120(34):8809-17. PubMed ID: 27487391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation.
    Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO
    Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers.
    Bisi N; Pinzi L; Rastelli G; Tonali N
    Molecules; 2024 Feb; 29(3):. PubMed ID: 38338465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does the electrical activity of neurons contribute to the pathogenesis of Alzheimer's Disease?
    Concepcion GP; Padlan EA
    Med Hypotheses; 2010 Jan; 74(1):27-8. PubMed ID: 19733011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-Membrane-Mimicking Lipid-Coated Nanoparticles Confer Raman Enhancement to Membrane Proteins and Reveal Membrane-Attached Amyloid-β Conformation.
    Bhowmik D; Mote KR; MacLaughlin CM; Biswas N; Chandra B; Basu JK; Walker GC; Madhu PK; Maiti S
    ACS Nano; 2015 Sep; 9(9):9070-7. PubMed ID: 26391443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural model of the amyloid fibril formed by beta(2)-microglobulin #21-31 fragment based on vibrational spectroscopy.
    Hiramatsu H; Goto Y; Naiki H; Kitagawa T
    J Am Chem Soc; 2005 Jun; 127(22):7988-9. PubMed ID: 15926803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The amyloid state of proteins: A boon or bane?
    Hassan MN; Nabi F; Khan AN; Hussain M; Siddiqui WA; Uversky VN; Khan RH
    Int J Biol Macromol; 2022 Mar; 200():593-617. PubMed ID: 35074333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent progress in understanding Alzheimer's β-amyloid structures.
    Fändrich M; Schmidt M; Grigorieff N
    Trends Biochem Sci; 2011 Jun; 36(6):338-45. PubMed ID: 21411326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of SERS Active Nanoprobe for Selective Adsorption and Detection of Alzheimer's Disease Biomarkers Based on Molecular Docking.
    Garnaik UC; Chandra A; Goel VK; Gulyás B; Padmanabhan P; Agarwal S
    Int J Nanomedicine; 2024; 19():8271-8284. PubMed ID: 39161360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of amyloid deposits in neurodegenerative diseases.
    Vidal R; Ghetti B
    Methods Mol Biol; 2011; 793():241-58. PubMed ID: 21913105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.